Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on LB Pharmaceuticals Inc Common Stock (NASDAQ:LBRX) on August 03, 2026. Market Context LB Pharmaceuticals Inc…
Read moreRating Change BTIG analysts reiterated a Buy rating on Castle Biosciences, Inc. (NASDAQ:CSTL) on August 03, 2026. Market Context Castle Biosciences, Inc.
Read moreRating Change Goldman Sachs analysts upgraded Coursera, Inc. (NYSE:COUR) from Sell to Neutral on August 03, 2026. Market Context Coursera, Inc.
Read moreRating Change Wedbush analysts reiterated a Neutral rating on Playtika Holding Corp. (NASDAQ:PLTK) on August 03, 2026. Market Context Playtika Holding Corp.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on WisdomTree, Inc. (NYSE:WT) on August 03, 2026. Market Context WisdomTree, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Hancock Whitney Corporation (NASDAQ:HWC) on August 03, 2026. Market Context Hancock Whitney Corporation operates…
Read moreRating Change Baird analysts reiterated a Outperform rating on Gates Industrial Corporation plc (NYSE:GTES) on August 03, 2026. Market Context Gates Industrial Corporation plc…
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Gates Industrial Corporation plc (NYSE:GTES) on August 03, 2026. Market Context Gates Industrial Corporation plc…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Gates Industrial Corporation plc (NYSE:GTES) on August 03, 2026. Market Context Gates Industrial Corporation…
Read moreRating Change Baird analysts reiterated a Neutral rating on Hyatt Hotels Corporation (NYSE:H) on August 03, 2026. Market Context Hyatt Hotels Corporation operates in the Consumer…
Read moreRating Change Wedbush analysts reiterated a Outperform rating on Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on August 03, 2026. Market Context Neurocrine Biosciences, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on August 03, 2026. Market Context Neurocrine Biosciences, Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Neutral rating on Mid-America Apartment Communities, Inc. (NYSE:MAA) on August 03, 2026. Market Context Mid-America Apartment…
Read moreRating Change Barclays analysts reiterated a Overweight rating on East West Bancorp, Inc. (NASDAQ:EWBC) on August 03, 2026. Market Context East West Bancorp, Inc.
Read moreRating Change B of A Securities analysts reiterated a Underperform rating on Best Buy Co., Inc. (NYSE:BBY) on August 03, 2026. Market Context Best Buy Co., Inc.
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Carpenter Technology Corp (NYSE:CRS) on August 03, 2026. Market Context Carpenter Technology Corp operates in the…
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Invitation Homes Inc. (NYSE:INVH) on August 03, 2026. Market Context Invitation Homes Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Essex Property Trust, Inc. (NYSE:ESS) on August 03, 2026. Market Context Essex Property Trust, Inc.
Read moreRating Change Mizuho analysts reiterated a Neutral rating on Alliant Energy Corporation (NASDAQ:LNT) on August 03, 2026. Market Context Alliant Energy Corporation operates in the…
Read moreRating Change BMO Capital analysts reiterated a Outperform rating on Alliant Energy Corporation (NASDAQ:LNT) on August 03, 2026. Market Context Alliant Energy Corporation operates…
Read more
